| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.071 | 0.03 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | 0.075 | 0.04 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.04 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.071 | 0.04 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.04 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | -0.066 | 0.04 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | -0.072 | 0.04 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.04 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.1 | 0.04 |